MDDCX
Price
$22.24
Change
-$0.55 (-2.41%)
Updated
Apr 3 closing price
Net Assets
3.81B
VEMIX
Price
$28.14
Change
-$0.54 (-1.88%)
Updated
Apr 3 closing price
Net Assets
110.13B
Ad is loading...

MDDCX vs VEMIX

Header iconMDDCX vs VEMIX Comparison
Open Charts MDDCX vs VEMIXBanner chart's image
BlackRock Emerging Mkts Inv A
Price$22.24
Change-$0.55 (-2.41%)
VolumeN/A
Net Assets3.81B
Vanguard Emerging Mkts Stock Idx Instl
Price$28.14
Change-$0.54 (-1.88%)
VolumeN/A
Net Assets110.13B
MDDCX vs VEMIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MDDCX vs. VEMIX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MDDCX is a Buy and VEMIX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
VEMIX has more cash in the bank: 110B vs. MDDCX (3.81B). VEMIX pays higher dividends than MDDCX: VEMIX (3.12) vs MDDCX (1.72). MDDCX was incepted earlier than VEMIX: MDDCX (30 years) vs VEMIX (25 years). MDDCX (1.36) is less costly to investors than VEMIX (0.09). MDDCX is a more actively managed with annual turnover of: 91.00 vs. VEMIX (8.00). MDDCX has a lower initial minimum investment than VEMIX: MDDCX (1000) vs VEMIX (5000000). VEMIX annual gain was more profitable for investors over the last year : 9.78 vs. MDDCX (-5.03). VEMIX return over 5 years is better than : 52.17 vs. MDDCX (24.35).
MDDCXVEMIXMDDCX / VEMIX
Total Expense Ratio1.120.091,244%
Annual Report Gross Expense Ratio1.360.091,511%
Fund Existence30 years25 years-
Gain YTD-1.7232.643-65%
Front Load5%N/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRA100N/A-
Net Assets3.81B110B3%
Annual Yield % from dividends1.723.1255%
Returns for 1 year-5.039.78-51%
Returns for 3 years-8.932.52-355%
Returns for 5 years24.3552.1747%
Returns for 10 years25.3827.6592%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IPOCX15.24N/A
N/A
Macquarie Systematic Em Mkts Eq C
PLCGX15.46N/A
N/A
Principal LargeCap Growth I R6
TFIFX43.46N/A
N/A
T. Rowe Price Financial Services I
CSSJX24.13N/A
N/A
Carillon Chartwell Small Cap C
LIFLX13.68N/A
N/A
Lord Abbett Focused Large Cap Value I